USNA - PRICE - USANA Health Sciences

This chart of the market valuation for USANA Health Sciences (USNA) is based on the operation of its own facilities in China and the US, where product quality is strictly monitored, and the current metric stands at 14.54. The business relies on powerful operating leverage and a network of independent agents, making sales expansion extremely cost-effective. Meanwhile, R&D is currently focused on the digitalization of nutraceutical selection and the targeted modernization of formulations.

The price history of USANA Health Sciences (USNA) reflects the market reaction to stable cash flows generated by regular nutraceutical purchases. The closing price captures the final share value, determining the current market capitalization of the business. This metric is calculated as the final equilibrium of supply and demand within the trading session. The price action allows for an assessment of the efficiency of the direct sales model. The asset is categorized as a consumer sector stock.